Navigation Links
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Date:12/11/2007

ater than 70 years of age, and demonstrated the safety profile of rosiglitazone to be consistent with the control medicine (sulfonylurea).

Importantly, the results of this study do not reproduce what is already known about the risk of CHF in TZD users. TZDs can cause fluid retention which can lead to or exacerbate heart failure. TZDs also have a similar increased risk of CHF. Yet, in this analysis, pioglitazone is not associated with an increased risk of CHF (Adjusted RR of 0.91 (95% CI = 0.52-1.59) whereas rosiglitazone is associated with 2 fold-increased risk of CHF (Adjusted RR = 1.98 and 95% CI=1.44-2.72) compared to oral anti-diabetic combination therapy. This is inconsistent with the product labeling.

Moreover, the authors of this retrospective analysis fail to acknowledge the findings of large epidemiological studies, encompassing over 1.3 million patients with type 2 diabetes, as well as other similar studies presented during the recent FDA Advisory Committee meeting. These studies have investigated whether use of rosiglitazone in the real world setting is associated with an increase in myocardial infarction or coronary revascularization. The majority of these studies show that rosiglitazone is not associated with an increased risk of myocardial infarction compared to other anti-diabetic agents.

GSK cites the following as examples of the limitations of this retrospective analysis:

-- As the authors state, patients on TZDs in their analysis may represent

an older, select group of patients with advanced diabetes and therefore

higher baseline risk for cardiovascular disease.

-- The ODB database is composed of a select group of patients.

Rosiglitazone is only prescribed for those patients who fail

treatment on metformin and sulfonylurea, or for whom sulfonylurea or

metformin are contraindicated. The rosiglitazone patients are

therefore ones with higher
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
9. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
10. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Cystic fibrosis (CF) is a genetic ... gastrointestinal organs. In particular, very thick mucus accumulates in ... difficult to clear, occludes the airways, and creates an ... frequently suffer from chronic biofilm infections, and ultimately succumb ... approach to treating the major challenges in the lungs ...
(Date:10/2/2014)... Mich. (PRWEB) October 02, 2014 MS ... with Hile Creative to refine its marketing approach. Backed ... MS Bioworks serves researchers in the biological sciences, including ... Bioworks has already seen substantial growth over the past ... with current customers, the company plans to launch a ...
(Date:10/2/2014)... (PRWEB) October 02, 2014 At a time ... Bel-Art Products has introduced a new kind of squeeze ... market is the Scienceware® Squeeze Rite™ Wash Bottle , ... tube position within the bottle reduces the waste of reagents, ... of those liquids. , “Easier to squeeze when compared to ...
(Date:10/2/2014)... CARLOS, Calif. and BRIDGEWATER, ... Corporation (NYSE: XON) , a leader in synthetic ... seventh largest generic drug manufacturer by volume in ... second Exclusive Channel Collaboration (ECC) for a target ... expression system, the goal of the collaboration is ...
Breaking Biology Technology:Synedgen to Present at North American Cystic Fibrosis Conference 2Synedgen to Present at North American Cystic Fibrosis Conference 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Wis . - The Medical College of Wisconsin ... National Institute of Neurological Disorders and Stroke ... , ,The research, which will be led by principal ... examine the link between oxygen deficit and loss of ...
... Green Bay, Wis. - For six years, Steve Matheys served ... experience during that period - 1998 to 2004 - convinced him ... for bigger and better things in the executive suite. , ,Provided ... is. , ,Matheys, who now serves as executive vice president of ...
... Milwaukee, Wis . - He is fast becoming one of ... and if he has his way chief information officers and ... when they move to fill IT staff openings. , ... during the Wisconsin Entrepreneur's Conference in Milwaukee, is ...
Cached Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3
(Date:9/30/2014)... farm runoff in Hawaii is causing tumors in endangered ... study, published Tuesday in the peer-reviewed open-access journal ... up in algae that the turtles eat, promoting the ... internal organs. , Scientists at Duke University, the University ... (NOAA) conducted the study to better understand the causes ...
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... pregnanteven with IVF? Here,s some hope: A new research ... The FASEB Journal , explains how scientists developed ... PAWP, which induced embryo development in human and mouse ... by the sperm cell during fertilization. , "We believe ... paradigm shift in our understanding of human fertilization by ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... dinner fat intake seem to influence negatively the sleep pattern ... be presented on Tuesday at SLEEP 2008, the 22nd Annual ... study, authored by Cibele Crispim, of the Federal University of ... 20-45 years of age, whose food intake was analyzed by ...
... forensic scientists at the University of Copenhagen has studied human ... to the iron age, and discovered a man who appears ... beings were as genetically diverse 2000 years ago as they ... than was previously thought. The findings also suggest that people ...
... A new book, Grounds for Knowledge , ... modern buildings and the striking landscape that surrounds them. ... L. Watson, who, together with her husband James D. Watson ... picturesque grounds of CSHL for almost four decades. The ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: